SCHEMBL5360376

SCHEMBL5360376

COc1ccc(-c2nc(C(CCCCNC(=O)OC(C)(C)C)NC(=O)OCc3ccccc3)c[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
HDAC1 Q13547 5/20 0.54
HDAC6 Q9UBN7 5/20 0.54
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
SYK P43405 1/20 0.44
HDAC3 O15379 4/20 0.43
HDAC4 P56524 4/20 0.43
HDAC7 Q8WUI4 4/20 0.43
HDAC2 Q92769 4/20 0.43
HDAC10 Q969S8 4/20 0.43
HDAC11 Q96DB2 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC9 Q9UKV0 4/20 0.43
HDAC5 Q9UQL6 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RECQL P46063 1/20 0.43
PAX8 Q06710 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360383 1.00 MAPT (0.55) MAPTHDAC1HDAC6L3MBTL1POLB
SCHEMBL5470629 0.90 HDAC6 (0.57) MAPTHDAC1HDAC6HDAC3HDAC4
SCHEMBL5470626 0.90 HDAC6 (0.57) MAPTHDAC1HDAC6HDAC3HDAC4
SCHEMBL8112086 0.86 HDAC1 (0.57) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL8113303 0.85 HDAC6 (0.74) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL5327671 0.85 HDAC1 (0.74) MAPTHDAC1HDAC6L3MBTL1POLB
SCHEMBL5327677 0.85 HDAC1 (0.74) MAPTHDAC1HDAC6L3MBTL1POLB
SCHEMBL4052446 0.83 MAPT (0.47) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL5363015 0.79 MAPT (0.60) MAPTHDAC1HDAC6L3MBTL1POLB
SCHEMBL5363018 0.79 MAPT (0.60) MAPTHDAC1HDAC6L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 MAPT 2802/4885HDAC1 1/4885HDAC6 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.